Abstract
Mitochondrial diseases, caused mainly by pathogenic mitochondrial DNA (mtDNA) mutations, pose major challenges due to the lack of effective treatments. Investigating the patterns of maternal transmission of mitochondrial diseases could pave the way for preventive approaches. In this study, we used DddA-derived cytosine base editors (DdCBEs) to generate two mouse models, each haboring a single pathogenic mutation in complex I genes (ND1 and ND5), replicating those found in human patients. Our findings revealed that both mutations are under strong purifying selection during maternal transmission and occur predominantly during postnatal oocyte maturation, with increased protein synthesis playing a vital role. Interestingly, we discovered that maternal age intensifies the purifying selection, suggesting that older maternal age may offer a protective effect against the transmission of deleterious mtDNA mutations, contradicting the conventional notion that maternal age correlates with increased transmitted mtDNA mutations. As collecting comprehensive clinical data is needed to understand the relationship between maternal age and transmission patterns in humans, our findings may have profound implications for reproductive counseling of mitochondrial diseases, especially those involving complex I gene mutations.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All source data are provided with this paper. Stereo-seq data that support the findings of this study have been deposited into STOmis DB of the China National GeneBank DataBase68 with accession number STT0000087. Further information supporting the findings of this study is available from M.J. upon reasonable request.
References
Picard, M. & Shirihai, O. S. Mitochondrial signal transduction. Cell Metab. 34, 1620–1653 (2022).
Gustafsson, C. M., Falkenberg, M. & Larsson, N.-G. Maintenance and expression of mammalian mitochondrial DNA. Annu. Rev. Biochem. 85, 133–160 (2016).
Stewart, J. B. et al. Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol. 6, e10 (2008).
Kauppila, J. H. K. et al. Base-excision repair deficiency alone or combined with increased oxidative stress does not increase mtDNA point mutations in mice. Nucleic Acids Res. 46, 6642–6669 (2018).
Stewart, J. B. & Chinnery, P. F. Extreme heterogeneity of human mitochondrial DNA from organelles to populations. Nat. Rev. Genet. 22, 106–118 (2021).
Wei, W. et al. Germline selection shapes human mitochondrial DNA diversity. Science 364, eaau6520 (2019).
Jenuth, J. P., Peterson, A. C., Fu, K. & Shoubridge, E. A. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat. Genet. 14, 146–151 (1996).
Brown, D. T., Samuels, D. C., Michael, E. M., Turnbull, D. M. & Chinnery, P. F. Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am. J. Hum. Genet. 68, 533–536 (2001).
Cree, L. M. et al. A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Nat. Genet. 40, 249–254 (2008).
Burr, S. P., Pezet, M. & Chinnery, P. F. Mitochondrial DNA heteroplasmy and purifying selection in the mammalian female germ line. Dev. Growth Differ. 60, 21–32 (2018).
Zaidi, A. A. et al. Bottleneck and selection in the germline and maternal age influence transmission of mitochondrial DNA in human pedigrees. Proc. Natl Acad. Sci. USA 116, 201906331 (2019).
Mok, B. Y. et al. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature 583, 631–637 (2020).
Mok, B. Y. et al. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nat. Biotechnol. 40, 1378–1387 (2021).
Lee, H. et al. Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases. Nat. Commun. 12, 1190 (2021).
Guo, J. et al. DdCBE mediates efficient and inheritable modifications in mouse mitochondrial genome. Mol. Ther. Nucleic Acids 27, 73–80 (2021).
Silva-Pinheiro, P. et al. A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome. Nat. Biomed. Eng. 7, 692–703 (2022).
Agip, A.-N. A., Blaza, J. N., Fedor, J. G. & Hirst, J. Mammalian respiratory complex I through the lens of cryo-EM. Annu. Rev. Biophys. 48, 165–184 (2019).
Grba, D. N. & Hirst, J. Mitochondrial complex I structure reveals ordered water molecules for catalysis and proton translocation. Nat. Struct. Mol. Biol. 27, 892–900 (2020).
Freyer, C. et al. Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission. Nat. Genet. 44, 1282–1285 (2012).
Kauppila, J. H. K. et al. A phenotype-driven approach to generate mouse models with pathogenic mtDNA mutations causing mitochondrial disease. Cell Rep. 16, 2980–2990 (2016).
Filograna, R. et al. Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse. Sci. Adv. 5, eaav9824 (2019).
Kremer, L. S. et al. A role for BCL2L13 and autophagy in germline purifying selection of mtDNA. PLoS Genet. 19, e1010573 (2022).
Fan, W. et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319, 958–962 (2008).
Hill, J. H., Chen, Z. & Xu, H. Selective propagation of functional mitochondrial DNA during oogenesis restricts the transmission of a deleterious mitochondrial variant. Nat. Genet. 46, 389–392 (2014).
Ma, H., Xu, H. & O’Farrell, P. H. Transmission of mitochondrial mutations and action of purifying selection in Drosophila melanogaster. Nat. Genet. 46, 393–397 (2014).
Lieber, T., Jeedigunta, S. P., Palozzi, J. M., Lehmann, R. & Hurd, T. R. Mitochondrial fragmentation drives selective removal of deleterious mtDNA in the germline. Nature 570, 380–384 (2019).
Palozzi, J. M. et al. Mitochondrial DNA quality control in the female germline requires a unique programmed mitophagy. Cell Metab. 34, 1809–1823 (2022).
Zhang, Y. et al. PINK1 inhibits local protein synthesis to limit transmission of deleterious mitochondrial DNA mutations. Mol. Cell 73, 1127–1137 (2019).
Chiang, A. C.-Y., McCartney, E., O’Farrell, P. H. & Ma, H. A genome-wide screen reveals that reducing mitochondrial DNA polymerase can promote elimination of deleterious mitochondrial mutations. Curr. Biol. 29, 4330–4336 (2019).
Chen, Z. et al. Mitochondrial DNA segregation and replication restrict the transmission of detrimental mutation. J. Cell Biol. 219, e201905160 (2020).
Arbeithuber, B. et al. Advanced age increases frequencies of de novo mitochondrial mutations in macaque oocytes and somatic tissues. Proc. Natl Acad. Sci. USA 119, e2118740119 (2022).
Rebolledo-Jaramillo, B. et al. Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA. Proc. Natl Acad. Sci. USA 111, 15474–15479 (2014).
Blakely, E. L. et al. LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation. Eur. J. Hum. Genet. 13, 623–627 (2005).
Liu, Q. et al. Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR/Cas systems. Sci. China Life Sci. 62, 1–7 (2019).
Kampjut, D. & Sazanov, L. A. The coupling mechanism of mammalian respiratory complex I. Science 370, eabc4209 (2020).
Kravchuk, V. et al. A universal coupling mechanism of respiratory complex I. Nature 609, 808–814 (2022).
Stewart, J. B. & Chinnery, P. F. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat. Rev. Genet. 16, 530–542 (2015).
Walker, M. A. et al. Purifying selection against pathogenic mitochondrial DNA in human T cells. N. Engl. J. Med. 383, 1556–1563 (2020).
Pulkes, T. et al. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann. Neurol. 46, 916–919 (1999).
Chol, M. et al. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J. Med. Genet. 40, 188–191 (2003).
Wang, S.-B. et al. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff–Parkinson–White syndrome and cardiomyopathy. Pediatr. Neonatol. 49, 145–149 (2008).
Wang, Z. et al. Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G>A mutation, and neuropathological findings in one autopsy case. Neuropathology 30, 606–614 (2010).
Sun, C., Bai, H., Xu, D., Xiao, Q. & Liu, Z. Mitochondrial 13513G>A mutation with low mutant load presenting as isolated Leber’s hereditary optic neuropathy assessed by next generation sequencing. Front. Neurol. 12, 601307 (2021).
Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 185, 1777–1792 (2022).
Fitzpatrick, S. L. et al. Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues. Endocrinology 139, 2571–2578 (1998).
McGrath, S. A., Esquela, A. F. & Lee, S. J. Oocyte-specific expression of growth/differentiation factor-9. Mol. Endocrinol. 9, 131–136 (1995).
Sato, M. et al. Identification of PGC7, a new gene expressed specifically in preimplantation embryos and germ cells. Mech. Dev. 113, 91–94 (2002).
Thoreen, C. C. et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109–113 (2012).
Gross, J. D. & Pears, C. J. Possible involvement of the nutrient and energy sensors mTORC1 and AMPK in cell fate diversification in a non-metazoan organism. Front. Cell Dev. Biol. 9, 758317 (2021).
Goul, C., Peruzzo, R. & Zoncu, R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat. Rev. Mol. Cell Biol. 24, 857–875 (2023).
Kim, J. & Guan, K.-L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63–71 (2019).
Zheng, W. et al. Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions. Hum. Mol. Genet. 23, 920–928 (2014).
Dou, X. et al. Short‐term rapamycin treatment increases ovarian lifespan in young and middle‐aged female mice. Aging Cell 16, 825–836 (2017).
Civiletto, G. et al. Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis. EMBO Mol. Med. 10, e8799 (2018).
Jiang, C. et al. GGPP-mediated protein geranylgeranylation in oocyte is essential for the establishment of oocyte-granulosa cell communication and primary-secondary follicle transition in mouse ovary. PLoS Genet. 13, e1006535 (2017).
Rodríguez-Nuevo, A. et al. Oocytes maintain ROS-free mitochondrial metabolism by suppressing complex I. Nature 607, 756–761 (2022).
Cao, L. et al. The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells. Nat. Genet. 39, 386–390 (2007).
Wai, T., Teoli, D. & Shoubridge, E. A. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat. Genet. 40, 1484–1488 (2008).
Guo, J. et al. Precision modeling of mitochondrial diseases in zebrafish via DdCBE-mediated mtDNA base editing. Cell Discov. 7, 78 (2021).
Clayton, D. A. & Shadel, G. S. Isolation of mitochondria from cells and tissues. Cold Spring Harb. Protoc. https://doi.org/10.1101/pdb.top074542 (2014).
Griffin, J., Emery, B. R., Huang, I., Peterson, C. M. & Carrell, D. T. Comparative analysis of follicle morphology and oocyte diameter in four mammalian species (mouse, hamster, pig, and human). J. Exp. Clin. Assist. Reprod. 3, 2 (2006).
Ye, S., Hu, J. J. & Yang, D. Tandem Payne/Dakin reaction: a new strategy for hydrogen peroxide detection and molecular imaging. Angew. Chem. Int. Ed. Engl. 57, 10173–10177 (2018).
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2, 100141 (2021).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009).
Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).
Zhang, H. et al. Mitochondrial DNA heteroplasmy is modulated during oocyte development propagating mutation transmission. Sci. Adv. 7, eabi5657 (2021).
Chen, F. Z. et al. CNGBdb: China National GeneBank DataBase. Hereditas (Beijing) 42, 799–809 (2020).
Acknowledgements
We thank the Westlake Laboratory Animal Resources Center for microinjection and mouse husbandry and Westlake Biomedical Research Core Facilities for technical support. We thank S. Bin (Nanjing Medical University) for the DdCBE backbones (with puromycin and without TALE) as a kind gift. M.J. was supported by the National Key Research and Development Program of China (2022YFC2702702); the National Natural Science Foundation of China (82271897); the Key R&D Program of Zhejiang (2024SSYS0033); and the Westlake Education Foundation. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.
Author information
Authors and Affiliations
Contributions
M.J. conceived and led the project. M.J., Y.R., X.D., J.C. and L.Z. designed and conducted most of the experiments. L.Z. and Z.X. constructed the mouse models. Q.L. sorted the immune cells from the blood and collected the sequencing results. J.G., S.L., Z.H. and M.K. assisted with the oocyte assay and Seahorse experiments. M.J. and Y.R. wrote the manuscript, with the help of X.D. and L.Z.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Aging thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Generation and characterization of mutant MEF lines.
(a) A schematic outlining the editing process of MEFs and the establishment of mutant, single-cell-derived MEF lines. Created with BioRender.com. (b) Depiction of the four pairs of DdCBE editing plasmids targeting the mouse ND1 gene, highlighting TALE-binding regions in gray-blue and the base editing window in black. Plasmid combinations are labeled according to their left or right positions, with -G1333 or −1397, and with -N or -C termini. Produced using BioRender. (c) Validation of Hi-TOM for quantifying mtDNA mutation loads, with the black line representing the line of unity (y = x) and the red dot/line indicating the mutation load of m.2820 G > A as analyzed by Hi-TOM and corresponding linear regression. (d) Mutation loads of m.2820 G > A across various MEF cell lines, each originating from individually sorted cell. (e) Comparative mutation loads of m.2820 G > A in the toe of 1 week of age and tails at the time of sacrifice (n = 37). Statistical significance assessed using a two-tailed unpaired t-test.
Extended Data Fig. 2 Tissue-specific ND1 mutation load variation across multiple ages.
(a–h) Mutation loads quantified across various somatic tissues and blood cells in the ND1 mutant mice: (a) Heart; (b) Liver; (c) Spleen; (d) Kidney; (e) Muscle; (f) Colon; (g) Brain; (h) Blood. Organ sample sizes are as follows: n = 3 for 8w; n = 3 for 9w; n = 4 for 12w; n = 5 for 14w; n = 2 for 22w; n = 2 for 23w; n = 3 for 25w; n = 4 for 31-32w; n = 3 for 41w; n = 5 for 43w; n = 3 for 80w; n = 3 for 98w. Data are mean ± SEM. (i–j) Mutation loads measured in blood and specific sorted cell types, including T cells, B cells, neutrophils, and monocytes. sample sizes: n = 17 animals (I) n = 13 animals (J). p-value from one-way ANOVA with Tukey’s multiple comparisons test.
Extended Data Fig. 3 Age-enhanced selection on ND1 mutations also occurs in F1 females.
(a) Correlation of F2 pup mutation loads (n = 186) with F1 female maternal mutation loads (n = 7), by litter. Different litters are color-coded. The y = x line shows expected transmission without selection, while y=ax+b is the linear regression of the mutation loads of F2 pups from different F1 females but produced in the same litter order. (b) Relationship between F1 female maternal age at conception and F2 pup normalized mutation load. Data are median ± 95% CI, with p-values from Kruskal-Wallis test and Dunn’s comparison. (c) Litter sizes of F1 females with varying mutation loads. Different colors indicate distinct litters. (d) Mutation load in M2 oocytes from F1 mothers at various ages. Data shown as median ± 95% CI; p-value via Kruskal-Wallis test with Dunn’s post hoc analysis. (e-f) Sperm counts (E) and sperm motility (F) from WT and ND1 mutant males at 24 weeks of age. Data are mean ± SEM. WT group n = 3; 77–79% mutation load group n = 3. Data are mean ± SEM; with p-values from two-tailed unpaired t-test.
Extended Data Fig. 4 Morphometry of mouse oocytes in primordial and antral follicles at multiple ages.
(a) Morphometric analysis of oocytes and surrounding somatic cells in primordial follicles from female mice at various developmental stages (P3, P7, P21, 8 weeks, 14 weeks, 22 weeks, and 32 weeks), and oocytes in antral follicles from P21 females. The diameters of oocytes (red) and somatic cells (soma) were measured. Oocytes are indicated in red, granulosa cells in black and red blood cells in purple. (b) The violin plots show the distribution of diameters for oocytes (n = 382 from 2 females) from primordial follicles in P3 mice, and granulosa cells (n = 314 from 2 females), delineating the variability in size of both cell types.
Extended Data Fig. 5 Age-enhanced purifying selection on m.2820 G > A occurs during oocyte maturation.
(a) Oocyte mutational loads in primordial follicles of P3 and P7 female mice. Oocytes with mutations >37% are marked in yellow. Individual female mutation loads are shown along the x-axis. Data presented as median ± 95% CI. P3 values correspond to those in Fig. 4e, now with expanded individual data. (b) Mutation loads in pups born to females of varying ages. Data are median ± 95% CI.This dataset correspond to those in Fig. 2e, with in-depth individual details. Female mutation loads are displayed along the x-axis. (c) Mutation load in M2 oocytes from females of different ages. Data are median ± 95% CI. This dataset correspond to those in Fig. 3a, with in-depth individual details. Female mutation loads are displayed along the x-axis. (d) Mutation loads throughout oocyte development and in pups from individual mothers. Data are median ± 95% CI. This dataset correspond to those in Fig. 4b, with in-depth individual details. Female mutation loads are displayed along the x-axis. (e) Representative PAS-stained ovarian section images from 14-week-old ND1 and WT mouse. (f) Counted follicle numbers at various developmental stages in ovarian sections from 14-week-old ND1 (n = 6 ovaries) and WT (n = 4 ovaries) mice. Data are mean ± SEM; with p-values from two-tailed unpaired t-test.
Extended Data Fig. 6 Age enhances purifying selection on the mouse m.12918 G > A mutation during maternal transmission.
(a) Mutation loads in pups born to individual females of varying ages. Data are median ± 95% CI. This dataset correspond to those in Fig. 6e, with in-depth individual details. Female mutation loads are displayed along the x-axis. (b) Mutation load in M2 oocytes from individual females of varying ages. Data are median ± 95% CI. This dataset correspond to those in Fig. 6g, with in-depth individual details. Female mutation loads are displayed along the x-axis. (c) Normalized mutation loads throughout oocyte development and in pups from multiple females at 22-week-old. Data are median ± 95% CI; with p-value from Kruskal-Wallis test followed by Dunn’s multiple comparisons. (d) Normalized mutation loads at different oocyte development and M2 from young females under 4 weeks old. Data are median ± 95% CI; with p-value from one-way ANOVA followed by Tukey’s multiple comparisons.
Extended Data Fig. 7 Spatial transcriptomic analysis of the ovary.
(a) Top row: H&E staining of ovarian sections from ND1 mutant and WT mice. Bottom row: Gdf9 gene expression profile obtained from spatial transcriptomics on adjacent sections for Stero-seq. Arrows indicate oocytes in secondary follicles (#1-10); while arrowheads point to oocytes in other follicles (#11, #12, #13, #16, #17), follicle-free regions (#15) or no mached follicle region (#14) in top H&E image (for detail in Supplementary Table 3). (b) Schematic diagram of the spatial transcriptomics analysis workflow applied in this study, detailing the step-by-step process from initial tissue sectioning to the final analysis and data interpretation.
Extended Data Fig. 8 Detailed assessment of rapamycin treatment efficacy in ovary and heart.
(a) Representative western blot of p-S6 levels in ovarian tissue following long-term treatment of either PBS or rapamycin in mice. (b) Quantitative analysis of (A). n = 4 for PBS-49d; n = 3 for Rapa-49d. Data are presented as the mean ± SEM, with p-values from two-tailed unpaired t-test. (c) Representative western blot of p-S6 levels in ovarian tissue following short-term treatment of either PBS or Rapamycin in mice. (d) Quantitative analysis of (C). n = 4 for PBS-49d; n = 3 for Rapa-21d. Data are mean ± SEM, with p-values from two-tailed unpaired t-test. (e) Representative western blot of p-S6 levels in heart tissue following short-, long-term treatment of rapamycin and PBS in mice. (f) Quantitative analysis of (E). n = 5 for PBS-49d; n = 5 for Rapa-49d; n = 3 for Rapa-21d. Data are mean ± SEM, with p-value from two-tailed unpaired t test. (g) The mutation load in heart tissues from mice treated with either PBS or Rapamycin. n = 5 for PBS-49d; n = 5 for Rapa-49d; n = 3 for Rapa-21d. Data are mean ± SEM, with p-values from two-tailed unpaired t-test. (h) Comparision of normalized mutational loads in M2 oocytes from treated (the same dataset as those in Fig. 8i) or non-treated mice (the same dataset as those in Fig. 3a). Each symbol represents an individual oocyte. Data are median ± 95% CI, with p-values via Kruskal-Wallis test and Dunn’s post hoc analysis.
Extended Data Fig. 9 No observable mitophagy in the ND1 mutant oocytes.
(a) Heatmap presenting detailed gene expression profiles related to mitophagy pathway from Stero-seq analysis, log-normalized for clarity using Seurat. (b) Representative TEM image of oocytes in secondary follicles from ND1 and WT mice. Four distinct views from each mouse are presented. A zoomed-in view highlights a potential autophagic structure. (c) Quantitative analysis of autophagysome-like structures in (B). Data are mean ± SEM. n = 60 for WT; n = 71 for ND1; with p-value from two-tailed Mann Whitney test. (d) Representative images of LC3B and MTCO1 co-staining in oocytes in secondary follicle of WT and ND1 mutant mice. The experiment was repeated three times. (e) Representative images of LAMP1 and TOMM20 co-staining in oocytes in secondary follicle of WT and ND1 mutant mice. The experiment was repeated five times.
Extended Data Fig. 10 Flow cytometry gating strategies.
(a) TMRM staining Gating: Initial gating excluded debris via FSC-A vs SSC-A, followed by doublet exclusion using FSC-A vs FSC-H. Finally, eFluor 780 positive dead cells were removed from the analysis. (b) Immune cell isolation Gating: Debris was first excluded using FSC-A vs SSC-A, with doublets subsequently removed via FSC-A vs FSC-H. Specific immune cell populations were identified using the following markers: B lymphocytes (CD45+CD3−CD19+), T lymphocytes (CD45+CD3+CD19−), Monocytes (CD45+CD3−CD19−CD11b+Ly6G−Ly6Chi), and Neutrophils (CD45+CD3−CD19−CD11b+Ly6G+).
Supplementary information
Supplementary Tables 1–12
mtDNA off-target and STomics analysis.
Source data
Source Data Fig. 1
Statistical Source Data.
Source Data Fig. 1
Unprocessed western blots and gels.
Source Data Fig. 2
Statistical Source Data.
Source Data Fig. 3
Statistical Source Data.
Source Data Fig. 4
Statistical Source Data.
Source Data Fig. 5
Statistical Source Data.
Source Data Fig. 6
Statistical Source Data.
Source Data Fig. 7
Statistical Source Data.
Source Data Fig. 8
Statistical Source Data.
Source Data Extended Data Fig. 1
Statistical Source Data.
Source Data Extended Data Fig. 2
Statistical Source Data.
Source Data Extended Data Fig. 3
Statistical Source Data.
Source Data Extended Data Fig. 4
Statistical Source Data.
Source Data Extended Data Fig. 5
Statistical Source Data.
Source Data Extended Data Fig. 6
Statistical Source Data.
Source Data Extended Data Fig. 8
Statistical Source Data.
Source Data Extended Data Fig. 8
Unprocessed western blots.
Source Data Extended Data Fig. 9
Statistical Source Data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ru, Y., Deng, X., Chen, J. et al. Maternal age enhances purifying selection on pathogenic mutations in complex I genes of mammalian mtDNA. Nat Aging (2024). https://doi.org/10.1038/s43587-024-00672-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s43587-024-00672-6
This article is cited by
-
Older age reduces mtDNA mutation inheritance
Nature Aging (2024)